跳至主導覽
跳至搜尋
跳過主要內容
長庚大學學術能量集萃 首頁
說明與常見問題
English
中文
首頁
學者概覽
研究單位
研究產出
研究計畫-專案
獎項
活動
新聞/媒體
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 嘉鴻
臨床副教授
,
中醫學系(含學士班、天然藥物、傳統中醫藥碩士班)
電子郵件
D000014710
cgu.edu
tw
h-index
h10-index
h5-index
1723
引文
24
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1381
引文
21
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1141
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1999
2024
每年研究產出
概覽
指紋
網絡
研究計畫-專案
(9)
研究產出
(113)
相近領域學者
(6)
指導學生論文
(1)
指紋
查看啟用 Chia-Hung Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Patient
100%
Maturity Onset Diabetes of the Young
63%
Glucose
47%
Insulin Dependent Diabetes Mellitus
38%
Diagnosis
35%
Inpatient
35%
Diabetes
34%
Therapeutic Procedure
30%
Leg Amputation
27%
Patient with Type 2 Diabetes
25%
Diabetic Foot
24%
Woman
24%
Insulin Infusion
20%
Gestational Diabetes
20%
Monitoring
19%
Insulin
18%
Diabetes Mellitus
18%
Glycemic
18%
Complication
18%
Analysis
17%
Foot Ulcer
17%
Alzheimer's Disease
17%
Foot Disease
17%
Combination Therapy
17%
Patient with Type 1 Diabetes
16%
Association
16%
Cardiovascular System
15%
Assessment
14%
Cohort Analysis
14%
Insulin Resistance
14%
Age
14%
Hypertension
13%
Pregnancy
13%
Ankle Brachial Index
13%
Child
13%
Nephropathy
12%
Incidence
12%
Limb
12%
Hospital
12%
Body Mass Index
12%
Survival
12%
Learning
12%
Prevalence
12%
N Methyl-D-Aspartate Receptor
11%
Hemoglobin A1c
11%
Plasma
11%
Glucagon-Like Peptide-1 Agonist
11%
Glucagon Like Peptide 1
11%
Amaurosis
11%
Incretin
11%
Nursing and Health Professions
Diabetes Mellitus
51%
Control
27%
Non Insulin Dependent Diabetes Mellitus
25%
Glucose
22%
Insulin Dependent Diabetes Mellitus
18%
Insulin
16%
Hypoglycemia
16%
Patient
13%
Insulin Infusion
12%
Insulin Treatment
11%
Continuous Glucose Monitoring
11%
Kidney Disease
11%
Hemoglobin A1c
10%
Glucose Blood Level
9%
Combination Therapy
8%
Cohort Analysis
7%
Diagnosis
7%
Insulin Resistance
7%
Hypertension
6%
End Stage Renal Disease
6%
Placebo
5%
Blindness
5%
Sodium Glucose Cotransporter 2 Inhibitor
5%
Empagliflozin
5%
Dapagliflozin
5%
Oral Antidiabetic Agent
5%
Algorithm
5%
Starch
5%
Aldosterone
5%
Renin
5%
Foot Disease
5%
Prospective Cohort Study
5%
Glucose Tolerance
5%
Drug Therapy
5%
Screening
5%
Chronic Kidney Failure
5%
Extract
5%
Pregnancy Diabetes Mellitus
5%
Primary Hyperaldosteronism
5%
Dipeptidyl Peptidase IV Inhibitor
5%
Colonoscopy
5%
Adenoma
5%
Polyp
5%
Tuberculosis
5%
Older Adult
5%
Multiple Endocrine Neoplasia
5%
Salicylate Sodium
5%
Antidiabetic Agent
5%
Polypectomy
5%
Leg Amputation
5%
Biochemistry, Genetics and Molecular Biology
Glucagon-Like Peptide-1
23%
Association
17%
Nested Gene
15%
Protein
15%
Age
15%
Glucose
14%
Insulin
14%
Learning
14%
Promoter Region
11%
Genome-Wide Association Study
11%
Receptor Gene
11%
Messenger RNA
11%
Methylation
10%
Glucagon-Like Peptide 1 Receptor
10%
D-Amino Acid Oxidase
10%
Adhesion Protein
10%
Single-Nucleotide Polymorphism
9%
Carbohydrate
9%
Allele
9%
Cohort Study
9%
Glucose Blood Level
9%
Neurotransmission
8%
Gender
8%
Artificial Intelligence
7%
mRNA Expression Level
7%
Accuracy
7%
Metabolite
7%
Case-Control Study
6%
Intestine Flora
6%
Secretion (Process)
6%
Serine
6%
Adjustment
5%
Training
5%
Magnetism
5%
Hyperglycemia
5%
Autoimmunity
5%
Extraction
5%
Radiomics
5%
Fibroblast Growth Factor
5%
Mineral Metabolism
5%
FGF21
5%
Angiopoietin
5%
Fibroblast Growth Factor 23
5%
Induced Pluripotent Stem Cell
5%
Retrospective Study
5%
Receptor Agonists
5%
Aldosterone
5%
Renin
5%
Stem Cell Line
5%
Exercise
5%
